Postpartum depression: pathophysiology, treatment, and emerging therapeutics

DE Stewart, SN Vigod - Annual review of medicine, 2019 - annualreviews.org
Postpartum depression (PPD) is common, disabling, and treatable. The strongest risk factor
is a history of mood or anxiety disorder, especially having active symptoms during …

Postpartum depression

DE Stewart, S Vigod - New England Journal of Medicine, 2016 - Mass Medical Soc
Key Clinical Points Postpartum Depression Postpartum depression is a common, disabling,
and treatable problem that affects the woman, infant, and family. Sensitive inquiry about …

Postpartum psychiatric disorders

S Meltzer-Brody, LM Howard, V Bergink… - Nature Reviews …, 2018 - nature.com
Pregnancy is a complex and vulnerable period that presents a number of challenges to
women, including the development of postpartum psychiatric disorders (PPDs). These …

Incorporating recognition and management of perinatal depression into pediatric practice

J Rafferty, G Mattson, MF Earls, MW Yogman… - …, 2019 - publications.aap.org
Background Depression is experienced by women most often during their childbearing
years. 1 Over the last several decades, research has revealed that untreated maternal …

RETRACTED ARTICLE: Anatomy of a Woebot®(WB001): agent guided CBT for women with postpartum depression

A Darcy, A Beaudette, E Chiauzzi… - Expert Review of …, 2022 - Taylor & Francis
Statement of Retraction Retraction: Anatomy of a Woebot®(WB001): Agent Guided CBT for
women with postpartum depression We, the Editor and Publisher of Expert Review of …

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: A landmark journey from concept to clinic in neurosteroid …

DS Reddy, RH Mbilinyi, E Estes - Psychopharmacology, 2023 - Springer
This article describes the critical role of neurosteroids in postpartum depression (PPD) and
outlines the landmark pharmacological journey of brexanolone as a first-in-class …

Postpartum depression: are you listening?

SD Falana, JM Carrington - The Nursing Clinics of North America, 2019 - europepmc.org
Postpartum depression (PPD) affects10% to 20% of women within the first year after birth
and 25% beyond the first year. PPD, despite advances in diagnosis and treatment, remains …

Academy of Breastfeeding Medicine Clinical Protocol# 21: breastfeeding in the setting of substance use and substance use disorder (revised 2023)

M Harris, DM Schiff, K Saia, S Muftu… - Breastfeeding …, 2023 - liebertpub.com
Background: The Academy of Breastfeeding Medicine (ABM) revised the 2015 version of the
substance use disorder (SUD) clinical protocol to review the evidence and provide updated …

Breastfeeding experiences and perspectives among women with postnatal depression: A qualitative evidence synthesis

DDS Tanganhito, D Bick, YS Chang - Women and Birth, 2020 - Elsevier
Background Studies show that postnatal depression affects around 10–16% of women
globally. It is associated with earlier cessation of breast feeding, which can negatively impact …

A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression

J Tabeshpour, F Sobhani, SA Sadjadi… - Phytomedicine, 2017 - Elsevier
Introduction Numerous adverse effects of antidepressants as well as the attitudes of
breastfeeding mothers, who prefer to consume herbal medicine rather than chemical drugs …